Best Healthcare Companies in Belgium
The 413 best Healthcare companies in Belgium in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Confo Therapeutics.
Belgium's Healthcare sector, ranked here by disclosed equity funding and recent momentum, spans 413 tracked companies with $503M in total disclosed capital. That's real money, but it's concentrated. Confo Therapeutics alone accounts for $106M of it, more than a fifth of the entire pool, with Xeos and Cognivia each pulling $16M and Genflow Biosciences adding $11M. No unicorns yet, which tells you something about where Belgian healthcare sits in its maturation curve. The global backdrop is enormous: the market crossed $2 trillion in 2020 and is forecast to reach roughly $2.6 trillion by 2025 at a 6.3% CAGR, driven by virtual care preferences and tech-enabled delivery models.
So what's moving inside the sector right now? Across 53 tracked healthcare apps, median install growth is running at plus-16% year over year, a quiet but durable signal that digital health engagement is compounding. Hot research themes cluster tightly around vaccine candidates, trials, and immunogenicity, which maps neatly onto Belgium's strengths in life sciences. Strict product safety compliance shapes every funding conversation here, and if you're evaluating these companies, that regulatory weight is baked into the timelines. I'd call the active investor list, Europa, Noshaq, SRIW, imec.istart, Sambrinvest, a solid foundation for a market still building toward its first breakout name.
- Healthcare Consumers in Asia-Pacific Prefer a Single Touchpoint
- Global Healthcare to Soar Above $2 Trillion in 2020 with Consumerism a
Ranked: Best Healthcare companies in Belgium
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Confo Therapeutics Drug discovery technology based on G-protein-coupled receptors (GPCRs) | $106M | 22 mo ago | 114 114 → 83 (-27%) · sector median +14% | Cedric Ververken CEO | WordPressMySQLPHP+15 | 37 patents GPCR-targeted peptide and small‑molecule therapeutics for MC4R metabolic disorders and AT2R pain relief | — |
| 2 | Ablynx Engaged in the discovery and development of nanobodies for a range of serious human diseases | $86M | 120 mo ago | 419 | — | — | 2,215 patents Single-domain (nanobody) antibody therapeutics and engineered FcRn antagonists for disease treatment | — |
| 3 | Movetis Provider of educational support and humanitarian aid for children | $64M | 233 mo ago | 29 | — | — | 12 patents Novel 5‑HT4 agonist/antagonist compounds for GI motility and asthma therapies | — |
| 4 | Eyed Pharma Manufacturer of ophthalmology drugs | $60M | 53 mo ago | 64 64 → 57 (-11%) · sector median +14% | — | WordPressMySQLPHP+15 | 36 patents Ocular drug delivery implants using eyelet-based intraocular devices for dry‑eye therapy | 1 job opening · 1 award |
| 5 | TiGenix Allogeneic stem cell-based therapies targeting autoimmune, inflammatory and heart diseases. | $19M | 103 mo ago | 89 | — | — | 81 patents Predictive lymphocyte biomarkers for mesenchymal stromal cell therapy efficacy | — |
| 6 | Sciensano Provider of health data analysis and public health services | $19M | 53 mo ago | 700 | — | DrupalPHPSalesforce+13 | 4 patents Patents concentrated in chemistry & materials | — |
| 7 | MaSTherCell Provider of services for the development of cell therapy products | $17M | 95 mo ago | 329 | — | — | — | — |
| 8 | Cognivia Provider of data modeling and patient insights for clinical trial optimization | $16M | 26 mo ago | 16 16 → 26 (+62%) · sector median +14% | Dominique Demolle CEO | WordPressApple iCloud MailMicrosoft 365+28 | — | — |
| 9 | Xeos Provider of PET-CT specimen imagers for the operating room, offering high-resolution molecular image… | $16M | 5 mo ago | 16 16 → 31 (+94%) · sector median +14% | — | Craft CMSPHPYii+12 | — | 1 job opening · 1 award |
| 10 | Opus Medical Portfolio of surgical products | $14M | 276 mo ago | — | Ed L. Chang Co-Founder | — | — | — |
| 11 | Intressa Vascular Provider of endovascular treatment services | $12M | 43 mo ago | 25 25 → 23 (-8%) · sector median +14% | Pierre Douette Chief Executive Officer | — | 13 patents Braided endovascular stents for cerebral arteries and dissected aortic repair | — |
| 12 | Teiko CDMO focused on providing services for cell and gene therapy products | $12M | 55 mo ago | 1 | — | WebflowAmazon Web ServicesCloudflare Turnstile+18 | — | 2 launchs |
| 13 | Genflow Biosciences CDMO focused on developing of gene therapies to reverse the aging processes | $11M | 3 mo ago | 5 | Eric Leire Founder & CEO | WordPress Block EditorBricksWordPress+14 | 5 patents Sirtuin‑6 gene therapy for metabolic, liver and muscular disease treatment | — |
| 14 | Montis Biosciences Research laboratory focused on development macrophages and tumor vasculature against solid tumors | $9M | 75 mo ago | 11 11 → 15 (+36%) · sector median +14% | — | — | 2 patents Design of C1q-binding therapeutic antibodies for immune modulation | — |
| 15 | InhaTarget Manufacturer of dry powder inhalation | $6M | 88 mo ago | 6 | — | Webflowcore-jsjQuery+14 | — | 1 partnership |
| 16 | Nuclivision Developer of software enhancing nuclear medicine imaging workflows for improved patient care | $6M | 13 mo ago | 6 | Tomas Brants Co-Founder | WebflowMarkerUsercentrics+13 | 2 patents Deep learning‑based enhancement and normalization of nuclear medical imaging data | 1 internship |
| 17 | DEO Provider of operating room process analysis and improvement recommendations | $5M | 55 mo ago | 12 12 → 28 (+133%) · sector median +14% | — | WordPressApple iCloud MailGoogle Workspace+40 | 20 patents Privacy-preserving anonymization of medical and multimedia data streams | 1 job opening |
| 18 | Cascador Health Provider of patient data management services for healthcare providers | $4M | 50 mo ago | 4 | Philip Taillieu Founder - CEO | — | — | 2 job openings |
| 19 | The European Institute for Innovation Through Health Data Provider of health data quality and interoperability solutions | $4M | 49 mo ago | 12 | — | WordPressMySQLPHP+22 | — | — |
| 20 | Formac Pharma Drug delivery solutions for poorly soluble APIs | $2M | 126 mo ago | 3 | Laurens Theunis Co-Founder | — | — | — |
| 21 | Certimed Provider of medical monitoring, certificate management, reporting, and other services | $2M | 41 mo ago | 34 | — | reCAPTCHACloudflare Bot ManagementOneTrust+3 | — | — |
| 22 | Deltaray Provider of X-ray equipment inspection services | $2M | 64 mo ago | 7 | Jan Sijbers Founder | — | 8 patents Automated X‑ray/CT imaging systems for pose‑agnostic inspection of objects | — |
| 23 | 4Tissue A biotech company that develops injectable solutions for regenerative medicine | $2M | 15 mo ago | — | Lana Van Damme Co-Founder & CSO | — | — | — |
| 24 | Radiomics Provider of clinical trials support & software services for medical devices manufacturers | $2M | 41 mo ago | 28 28 → 25 (-11%) · sector median +14% | — | WordPressApple iCloud MailMicrosoft 365+13 | — | — |
| 25 | seeding science Manufacturer of drug development and drug research services to biopharma | $1M | 100 mo ago | 1 | — | — | — | — |
| 26 | Qointa From quantified self (ehealth) to quantified patient to qualified patient (ecare) to qualified subject… | $1M | 129 mo ago | — | Rudiger Mees Founder | — | — | — |
| 27 | simAbs SimAbs is a center of excellence for continuous bioprocessing, offering a platform that enables fast… | $1M | 32 mo ago | 5 | Koen Dierckx Co-Founder & CEO | — | 5 patents Continuous perfusion bioreactor control and integrated bioprocess production platforms | — |
| 28 | ImmunXperts CRO specializing in human immune system based bioassay development services | $1M | 115 mo ago | 22 | — | — | — | — |
| 29 | Cell Matters CDMO focused on manufacturing of cell therapy products | $872K | 100 mo ago | 6 | Delphine Connan Co-Founder | — | 10 patents Formulating cryopreservation solutions for preserving biological materials | — |
| 30 | SEPS Pharma Pharma company developing prodrug approaches and drug delivery systems | $707K | 65 mo ago | 9 | Yves Gonnissen Co-Founder & Managing Director | — | — | — |
| 31 | Kreavet Provider of scientific support for sustainable animal health solutions | $403K | 28 mo ago | 2 | — | — | — | — |
| 32 | Exothera CDMO focused on provider of clinical trial services to biopharma sector | $402K | 44 mo ago | 131 | Jose Castillo Co-Founder | WordPressMySQLPHP+25 | 16 patents Downstream bioprocessing: cell culture harvest clarification and protein purification using flexible liners | — |
| 33 | EAPM Healthcare project focused on improving patient care by accelerating the development and delivery of… | $383K | 72 mo ago | — | — | — | — | — |
| 34 | ChromaCure Provider of cancer therapies development services | $309K | 63 mo ago | 5 | Cedric Blanpain Founder | — | — | — |
| 35 | Ceres Pharma Manufactures a range of nutritinal supplements | $198K | 30 mo ago | 31 | Marc Coucke Co-Founder | anime.jsNginxMicrosoft Advertising+10 | — | 4 job openings |
| 36 | Helicus Provider of healthcare & management consulting, drone transportation, and other services | $198K | 43 mo ago | 5 | — | WordPressMySQLPHP+20 | — | 1 partnership |
| 37 | Plastiflex Development and manufacturer of hose systems and related components | $138K | 228 mo ago | 26 | Lewis Herrmann Co-Founder | Microsoft ASP.NETBootstrapAzure+6 | 74 patents Patents concentrated in mechanical & energy engineering | 1 expansion |
| 38 | Zebra Academy Provider of telemedicine services tailored to students, offering mental health support from the comfort of… | $109K | 111 mo ago | 1 | Helio Tellez Co-Founder | — | — | — |
| 39 | Lilo Health Provider of a patient engagement platform for nephrologists | $100K | 53 mo ago | 10 | Alexandra Bendicakova Co-Founder | — | — | — |
Top 12 Healthcare companies in Belgium
#1
Public · Charleroi, Wallonia · founded 2020 · 5 employees$10.6Mraised▾
CDMO focused on developing of gene therapies to reverse the aging processes
- Mar 2026Grant (prize money)$4.7M
- Oct 2024Grant (prize money)$1.3M
- Apr 2024Post IPO$901.1K
- Mar 2022Grant (prize money)$3.7M
#2
Series B · Ghent, Flanders · founded 2019 · 16 employees$16.3Mraised▾
Xeos is a company that specializes in specimen imaging for surgical procedures. Their flagship product, the XEOS AURA 10, is the first-ever PET-CT Specimen Imager for the operating room. They aim to provide value for patients, surgeons, and imaging professionals.
- Jan 2026Series B$16.3M
#3
Series B · Brussels, Brussels · founded 2015 · 114 employees$105.9Mraised▾
Confo Therapeutics a spin-off from the Vrije Universiteit Brussel and VIB is a drug discovery company building a portfolio of products for multiple diseases. Its pipeline drugs based on its proprietary Confo technology. The technology locks inherent unstable functional confirmations of GPCR and this claimed to act as a starting point for drug discovery and it is a tool for selectively stabilization of specific conformational states of membrane proteins.
- Jul 2024Series B$65.1M
- Mar 2024Grant (prize money)$1.7M
- Mar 2021Grant (prize money)$1.2M
- Jun 2019Grant (prize money)$1.9M
#4
Seed · Ghent, Flanders · founded 2022 · 6 employees$5.7Mraised▾
Developer of software enhancing nuclear medicine imaging workflows for improved patient care. The software solutions assist physicians throughout their workflow, from image acquisition to diagnosis and follow-up. The company's flagship product delivers enhanced PET images that aim to boost patient safety and streamline operations for more efficient imaging centers. By reducing radiation, costs, and logistical barriers, the goal is to make nuclear imaging more available, giving patients faster access to the right treatment. More efficient use of radiotracers will also lessen the environmental impact, fostering a more sustainable healthcare system.
- Apr 2025Seed$5.7M
- 2022Seed—
#5
Seed · Belgium · founded 2023$1.6Mraised▾
A biotech company that develops injectable solutions for regenerative medicine. It is involved in the development of regenerative medicine solutions, utilizing advanced bio-interactive hydrogels to repair and regenerate damaged tissues. It offers a wide range of therapeutic areas and applications for its proprietary polymer or hydrogel toolbox.
- Feb 2025Seed$1M
- Feb 2025Grant (prize money)$524.4K
#6
Series B · Mont Saint Guibert, Wallonia · founded 2013 · 16 employees$16.5Mraised▾
Provider of data modeling and patient insights for clinical trial optimization. It offers solutions to predict patient behavior and drug responses, aiming to improve the predictability of clinical trials. The company focuses on reducing data variability caused by placebo response and patient heterogeneity to demonstrate treatment efficacy. It also provides tools to predict patient nonadherence and dropout risk, helping to strengthen patient engagement and improve study power for more informed clinical development decisions.
- Apr 2024Series B$16.5M
#7
Series B · Liege, Wallonia · founded 2013 · 64 employees$59.9Mraised▾
Manufacturer of ophthalmology drugs
- Jan 2022Series B$51M
- May 2019Series A$8.9M
- May 2019Conventional Debt$22.3M
#8
Funding Raised · Belgium · founded 2018 · 700 employees$18.8Mraised▾
Provider of health data analysis and public health services. This entity conducts health and disease monitoring, assesses the effectiveness and safety of vaccines and medical products, analyzes food safety, and monitors environmental health. It offers services such as analysis requests, data collection, external quality assessment, control and safety assessment, and licensing. The organization also provides health information, addresses health threats, and conducts research, publishing reports and findings to support health policy. They perform quality assessments for third parties and support various surveillance networks.
- Jan 2022Grant (prize money)$107.1K
- Nov 2021Grant (prize money)$589.5K
- Oct 2021Grant (prize money)$533.4K
- Jun 2021Grant (prize money)$23.4K
#9
Acquired · Ghent, Flanders · founded 2001 · 419 employees$86.3Mraised▾
Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious human diseases, including inflammation, hematology, oncology and pulmonary diseases. The Company has approximately 45 proprietary and partnered projects in the pipeline and five nanobodies in clinical development.
#10
Series B · Gembloux, Wallonia · founded 1998 · 25 employees$11.8Mraised▾
Provider of endovascular treatment services
#11
Deadpooled · Turnhout, Flanders · founded 2006 · 29 employees$63.7Mraised▾
Provider of educational support and humanitarian aid for children. This organization works to improve the lives of children globally, focusing on providing quality education, particularly in areas affected by poverty, conflict, or emergencies. Their initiatives include supporting school meals, providing educational materials, and creating safe learning environments. They also offer various avenues for individuals and corporations to contribute to their mission. The organization's efforts aim to empower children through education, ensuring their well-being and development.
#12
Series A · Brussels, Brussels · founded 2020 · 1 employees$11.6Mraised▾
Developer of an immune profiling platform designed to help deliver life-changing therapies to those who need them. The company's platform ascertains the immune features associated with response, rational targets for suggested combinations, and the abundance and activation scores of different immune cell types, enabling clinicians to make informed decisions around patient response and drive new pathway discoveries.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.